Tumor Biomechanics Alters Metastatic Dissemination of Triple Negative Breast Cancer via Rewiring Fatty Acid Metabolism
Elysse C. Filipe(Garvan Institute of Medical Research), Thomas R. Cox(Garvan Institute of Medical Research)
Cited by 23
Related Papers
Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
|Oncotarget|2017|107
The importance of developing therapies targeting the biological spectrum of metastatic disease
|Clinical & Experimental Metastasis|2019|13